VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $96,000 | -5.0% | 8,900 | 0.0% | 0.00% | – |
| Q1 2022 | $101,000 | -23.5% | 8,900 | +9.9% | 0.00% | – |
| Q4 2021 | $132,000 | -1.5% | 8,100 | +2.5% | 0.00% | – |
| Q3 2021 | $134,000 | -15.7% | 7,900 | 0.0% | 0.00% | – |
| Q2 2021 | $159,000 | +35.9% | 7,900 | 0.0% | 0.00% | – |
| Q1 2021 | $117,000 | +14.7% | 7,900 | 0.0% | 0.00% | – |
| Q4 2020 | $102,000 | +39.7% | 7,900 | 0.0% | 0.00% | – |
| Q3 2020 | $73,000 | -37.6% | 7,900 | -8.1% | 0.00% | -100.0% |
| Q3 2019 | $117,000 | -52.8% | 8,600 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $248,000 | +18.7% | 17,200 | +62.3% | 0.00% | 0.0% |
| Q1 2019 | $209,000 | -5.0% | 10,600 | +23.3% | 0.00% | 0.0% |
| Q4 2018 | $220,000 | +5.3% | 8,600 | -18.9% | 0.00% | 0.0% |
| Q3 2018 | $209,000 | 0.0% | 10,600 | -2.8% | 0.00% | 0.0% |
| Q2 2018 | $209,000 | +15.5% | 10,900 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $181,000 | 0.0% | 10,900 | -1.8% | 0.00% | 0.0% |
| Q4 2017 | $181,000 | 0.0% | 11,100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $181,000 | -1.6% | 11,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $184,000 | +17.2% | 11,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $157,000 | -18.7% | 11,100 | -7.5% | 0.00% | -50.0% |
| Q4 2016 | $193,000 | +22.9% | 12,000 | -38.5% | 0.00% | 0.0% |
| Q1 2016 | $157,000 | -24.5% | 19,500 | -9.3% | 0.00% | 0.0% |
| Q4 2015 | $208,000 | -12.2% | 21,500 | +2.4% | 0.00% | -33.3% |
| Q3 2015 | $237,000 | -7.4% | 21,000 | +4.0% | 0.00% | 0.0% |
| Q2 2015 | $256,000 | +43.0% | 20,200 | +5.2% | 0.00% | +50.0% |
| Q1 2015 | $179,000 | -40.9% | 19,200 | -8.1% | 0.00% | -50.0% |
| Q4 2014 | $303,000 | +49.3% | 20,900 | +6.6% | 0.00% | +33.3% |
| Q3 2014 | $203,000 | -35.4% | 19,600 | +1.0% | 0.00% | -40.0% |
| Q2 2014 | $314,000 | -0.3% | 19,400 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $315,000 | +31.2% | 19,400 | +2.1% | 0.01% | +25.0% |
| Q4 2013 | $240,000 | +18.2% | 19,000 | +2.7% | 0.00% | 0.0% |
| Q3 2013 | $203,000 | – | 18,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |